Establishing reliable miRNA-cancer association network based on text-mining method

Computational and Mathematical Methods in Medicine

Volumn 2014, Issue , 2014, Pages

  Li, Lun ^a   Hu, Xingchi ^a   Yang, Zhaowan ^a   Jia, Zhenyu ^b,c,d   Fang, Ming ^a   Zhang, Libin ^a   Zhou, Yanhong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF AKRON   (United States)

^c Northeastern Ohio Medical University   (United States)

^d GUIZHOU EDUCATION UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; TEXT MINING;

CANCER PATHOGENESIS; CANCER THERAPY; MICRORNAS; NETWORK LEVEL; NETWORK-BASED; RANDOM WALK ALGORITHMS;

RNA;

LET 7; MICRORNA; MICRORNA 10; MICRORNA 122; MICRORNA 124; MICRORNA 126; MICRORNA 146; MICRORNA 15; MICRORNA 155; MICRORNA 16; MICRORNA 17; MICRORNA 181; MICRORNA 193; MICRORNA 199; MICRORNA 200; MICRORNA 203; MICRORNA 205; MICRORNA 21; MICRORNA 221; MICRORNA 223; MICRORNA 224; MICRORNA 23; MICRORNA 27; MICRORNA 29; MICRORNA 30; MICRORNA 34; MICRORNA 520; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CARCINOGENESIS; COLORECTAL CANCER; DATA BASE; DATA MINING; ESOPHAGUS CANCER; HUMAN; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MELANOMA; MIRNA CANCER ASSOCIATION NETWORK; MOUTH CANCER; MYELOMA; NEOPLASM; NONHODGKIN LYMPHOMA; ONLINE SYSTEM; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; RANDOM WALK WITH RESTART ALGORITHM; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; STOMACH CANCER; TEXT MINING METHOD; THYROID CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; AREA UNDER THE CURVE; BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; LABORATORY DIAGNOSIS; METABOLISM; PROBABILITY; PROCEDURES; REPRODUCIBILITY;

ALGORITHMS; AREA UNDER CURVE; COMPUTATIONAL BIOLOGY; DATA MINING; FALSE POSITIVE REACTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; NEOPLASMS; PROBABILITY; REPRODUCIBILITY OF RESULTS;

EID: 84901276711     PISSN: 1748670X     EISSN: 17486718     Source Type: Journal    
DOI: 10.1155/2014/746979     Document Type: Article

References (49)

1. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5 (Pubitemid 38167318)
2. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5 (Pubitemid 38167318)
3. Cheng A. M., Byrom M. W., Shelton J., Ford L. P., Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Research 2005 33 4 1290 1297 2-s2.0-14844364472 10.1093/nar/gki200 (Pubitemid 41439922)
4. Harfe B. D., MicroRNAs in vertebrate development. Current Opinion in Genetics and Development 2005 15 4 410 415 2-s2.0-22144477115 10.1016/j.gde.2005.06.012 (Pubitemid 40982092)
5. Wienholds E., Kloosterman W. P., Miska E., Alvarez-Saavedra E., Berezikov E., De Bruijn E., Horvitz H. R., Kauppinen S., Plasterk R. H. A., Cell biology: microRNA expression in zebrafish embryonic development. Science 2005 309 5732 310 311 2-s2.0-22044458072 10.1126/science.1114519 (Pubitemid 40967869)
6. Shah A. A., Leidinger P., Blin N., Meese E., miRNA: small molecules as potential novel biomarkers in cancer. Current Medicinal Chemistry 2010 17 36 4427 4432 2-s2.0-78649778529 10.2174/092986710794182980
7. Huang S., He X., The role of microRNAs in liver cancer progression. British Journal of Cancer 2011 104 2 235 240 2-s2.0-78751575782 10.1038/sj.bjc.6606010
8. Krutovskikh V. A., Herceg Z., Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. BioEssays 2010 32 10 894 904 2-s2.0-77957197569 10.1002/bies.201000040
9. Brase J. C., Wuttig D., Kuner R., Sültmann H., Serum microRNAs as non-invasive biomarkers for cancer. Molecular Cancer 2010 9, article 306 2-s2.0-78649325763 10.1186/1476-4598-9-306
10. Farazi T. A., Spitzer J. I., Morozov P., Tuschl T., MiRNAs in human cancer. Journal of Pathology 2011 223 2 102 115 2-s2.0-78650034475 10.1002/path.2806
11. Tazawa H., Kagawa S., Fujiwara T., MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors. Expert Opinion on Biological Therapy 2011 11 2 145 155 2-s2.0-78651346918 10.1517/14712598.2011.542749
12. Lu M., Zhang Q., Deng M., Miao J., Guo Y., Gao W., Cui Q., An analysis of human microRNA and disease associations. PLoS ONE 2008 3 10 2-s2.0-54849408182 10.1371/journal.pone.0003420 e3420
13. Jiang Q., Wang Y., Hao Y., Juan L., Teng M., Zhang X., Li M., Wang G., Liu Y., miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Research 2009 37 1 D98 D104 2-s2.0-58149179989 10.1093/nar/gkn714
14. Chen X., Liu M. X., Yan G. Y., RWRMDA: predicting novel human microRNA-disease associations. Molecular BioSystems 2012 8 10 2792 2798 10.1039/c2mb25180a
15. Jiang Q., Hao Y., Wang G., Juan L., Zhang T., Teng M., Liu Y., Wang Y., Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Systems Biology 2010 4 1, article S2 2-s2.0-77953888015 10.1186/1752-0509-4-S1-S2
16. Chen H., Zhang Z., Prediction of associations between OMIM diseases and microRNAs by random walk on OMIM disease similarity network. The Scientific World Journal 2013 2013 6 204658 10.1155/2013/204658
17. Lussier Y. A., Stadler W. M., Chen J. L., Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures. Journal of the American Medical Informatics Association 2012 19 2 156 160 2-s2.0-84857180012 10.1136/amiajnl-2011-000419
18. Reinhart B. J., Slack F. J., Basson M., Pasquienelll A. E., Bettlnger J. C., Rougvle A. E., Horvitz H. R., Ruvkun G., The 21-nucleotide let -7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000 403 6772 901 906 2-s2.0-0034708122 10.1038/35002607 (Pubitemid 30130993)
19. Ambros V., Bartel B., Bartel D. P., Burge C. B., Carrington J. C., Chen X., Dreyfuss G., Eddy S. R., Griffiths-Jones S., Marshall M., Matzke M., Ruvkun G., Tuschl T., A uniform system for microRNA annotation. RNA 2003 9 3 277 279 2-s2.0-0037370020 10.1261/rna.2183803 (Pubitemid 36246165)
20. Griffiths-Jones S., Saini H. K., Van Dongen S., Enright A. J., miRBase: tools for microRNA genomics. Nucleic Acids Research 2008 36 1 D154 D158 2-s2.0-38549150275 10.1093/nar/gkm952 (Pubitemid 351149713)
21. Fisher R. A., On the mathematical foundations of theoretical statistics. Philosophical Transactions of the Royal Society of London Series A 1922 222 309 368
22. Le D.-H., Kwon Y.-K., GPEC: a cytoscape plug-in for random walk-based gene prioritization and biomedical evidence collection. Computational Biology and Chemistry 2012 37 17 23 2-s2.0-84858250709 10.1016/j.compbiolchem.2012.02. 004
23. Yang Z., Ren F., Liu C., He S., Sun G., Gao Q., Yao L., Zhang Y., Miao R., Cao Y., Zhao Y., Zhong Y., Zhao H., DbDEMC: a database of differentially expressed miRNAs in human cancers. BMC Genomics 2010 11 4, article S5 2-s2.0-78649778244 10.1186/1471-2164-11-S4-S5
24. Wang D., Wang J., Lu M., Song F., Cui Q., Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases. Bioinformatics 2010 26 13 1644 1650 2-s2.0-77954193356 10.1093/bioinformatics/btq241 btq241
25. Ling K.-H., Brautigan P. J., Hahn C. N., Daish T., Rayner J. R., Cheah P.-S., Raison J. M., Piltz S., Mann J. R., Mattiske D. M., Thomas P. Q., Adelson D. L., Scott H. S., Deep sequencing analysis of the developing mouse brain reveals a novel microRNA. BMC Genomics 2011 12, article 176 2-s2.0-79953280104 10.1186/1471-2164-12-176
26. Vinall R. L., Kent M. S., White D. R. W., Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma. American Journal of Veterinary Research 2012 73 10 1626 1633 10.2460/ajvr.73.10.1626
27. Speranza M. C., Frattini V., Pisati F., Kapetis D., Porrati P., NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget 2012 3 723 734
28. Campanini M. L., Colli L. M., Paixao B. M. C., Cabral T. P. F., Amaral F. C., Machado H. R., Neder L. S., Saggioro F., Moreira A. C., Antonini S. R. R., de Castro M., CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas. Hormones and Cancer 2010 1 4 187 196 2-s2.0-78650213872 10.1007/s12672-010-0041-7
29. Kang H.-W., Wang F., Wei Q., Zhao Y.-F., Liu M., Li X., Tang H., miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. FEBS Letters 2012 586 6 897 904 2-s2.0-84858702643 10.1016/j.febslet. 2012.02.020
30. Wang G., Chan E. S., Kwan B. C., Li P. K., Yip S. K., Expression of microRNAs in the urine of patients with bladder cancer. Clinical Genitourinary Cancer 2012 10 2 106 113 10.1016/j.clgc.2012.01.001
31. Poltronieri P., D'Urso P. I., Mezzolla V., D'Urso O. F., Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours. Chemical Biology and Drug Design 2013 81 1 79 84 10.1111/cbdd.12002
32. Rosati J., Spallotta F., Nanni S., Grasselli A., Antonini A., Vincenti S., Presutti C., Colussi C., D'Angelo C., Biroccio A., Farsetti A., Capogrossi M. C., Illi B., Gaetano C., Smad-interacting protein-1 and microRNA 200 family define a nitric oxide-dependent molecular circuitry involved in embryonic stem cell mesendoderm differentiation. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 4 898 907 2-s2.0-79953744099 10.1161/ATVBAHA.110.214478
33. Chen D., Sun Y., Wei Y., Zhang P., Rezaeian A. H., LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nature Medicine 2012 18 10 1511 1517 10.1038/nm.2940
34. Rokah O. H., Granot G., Ovcharenko A., Modai S., Pasmanik-Chor M., Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. PLoS ONE 2012 7 4 e35501 10.1371/journal.pone.0035501
35. Bhaskaran M., Xi D., Wang Y., Huang C., Narasaraju T., Identification of microRNAs changed in the neonatal lungs in response to hyperoxia exposure. Physiological Genomics 2012 44 20 970 980 10.1152/physiolgenomics.00145.2011
36. Nugent M., Miller N., Kerin M. J., Circulating miR-34a levels are reduced in colorectal cancer. Journal of Surgical Oncology 2012 106 8 947 952 10.1002/jso.23174
37. Schwabe R. F., Wang T. C., Targeting liver cancer: first steps toward a miRacle? Cancer Cell 2011 20 6 698 699 2-s2.0-83455263898 10.1016/j.ccr.2011.11. 021
38. Huang J.-J., Yu J., Li J.-Y., Liu Y.-T., Zhong R.-Q., Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma. Medical Oncology 2012 29 4 2402 2408 2-s2.0-84858738054 10.1007/s12032-012-0210-3
39. Furuta M., Kozaki K.-I., Tanaka S., Arii S., Imoto I., Inazawa J., miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2009 31 5 766 776 2-s2.0-77952299722 10.1093/carcin/bgp250
40. Ren Y., Gao J., Liu J. Q., Wang X. W., Gu J. J., Differential signature of fecal microRNAs in patients with pancreatic cancer. Molecular Medicine Reports 2012 6 201 209
41. Wiklund E. D., Gao S., Hulf T., Sibbritt T., Nair S., Costea D. E., Villadsen S. B., Bakholdt V., Bramsen J. B., Sørensen J. A., Krogdahl A., Clark S. J., Kjems J., MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS ONE 2011 6 11 2-s2.0-81555212307 10.1371/journal.pone.0027840 e27840
42. Zhao Y., Xie P., Fan H., Genomic profiling of MicroRNAs and proteomics reveals an early molecular alteration associated with tumorigenesis induced by MC-LR in mice. Environmental Science and Technology 2012 46 1 34 41 2-s2.0-84855311755 10.1021/es201514h
43. Murino P., Mammucari M., Borrelli D., Pepe A., Giugliano M. F., Morra A., Panelli G., Manzo R., Ravo V., Muto P., Role of immediate-release morphine (MIR) in the treatment of predictable pain in radiotherapy. Journal of Pain and Palliative Care Pharmacotherapy 2011 25 2 121 124 2-s2.0-79958290912 10.3109/15360288.2011.554488
44. Marchini S., Cavalieri D., Fruscio R., Calura E., Garavaglia D., Nerini I. F., Mangioni C., Cattoretti G., Clivio L., Beltrame L., Katsaros D., Scarampi L., Menato G., Perego P., Chiorino G., Buda A., Romualdi C., D'Incalci M., Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. The Lancet Oncology 2011 12 3 273 285 2-s2.0-79952041791 10.1016/S1470-2045(11)70012-2
45. Jiao L. R., Frampton A. E., Jacob J., Pellegrino L., Krell J., Giamas G., Tsim N., Vlavianos P., Cohen P., Ahmad R., Keller A., Habib N. A., Stebbing J., Castellano L., Micrornas targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS ONE 2012 7 2 2-s2.0-84857468335 10.1371/journal.pone.0032068 e32068
46. Li C. L., Nie H., Wang M., Su L. P., Li J. F., microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis. Oncology Reports 2012 27 6 1960 1966 10.3892/or.2012.1719
47. Zhou C. H., Yang S. F., Li P. Q., Human Lung Cancer cell line SPC-A1 contains cells with characteristics of cancer stem cells. Neoplasma 2012 59 6 685 692 10.4149/neo-2012-087
48. Liu Z., Zhu J., Cao H., Ren H., Fang X., miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. International Journal of Oncology 2012 40 5 1553 1560 2-s2.0-84859324831 10.3892/ijo.2012.1342
49. Bishop J. A., Benjamin H., Cholakh H., Chajut A., Clark D. P., Westra W. H., Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clinical Cancer Research 2010 16 2 610 619 2-s2.0-74549118209 10.1158/1078-0432.CCR-09-2638